Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Motivation levels and white matter microstructure in children living with HIV.

Scientific reports·2024
Same author

A comparison of vitamin D and cathelicidin (LL-37) levels between patients with active TB and their healthy contacts in a high HIV prevalence setting: a prospective descriptive study.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2021
Same author

Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa.

BMC infectious diseases·2020
Same author

Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.

The New England journal of medicine·2020
Same author

Tuberculosis in Hospitalized Patients With Human Immunodeficiency Virus: Clinical Characteristics, Mortality, and Implications From the Rapid Urine-based Screening for Tuberculosis to Reduce AIDS Related Mortality in Hospitalized Patients in Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2019
Same author

Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.

PLoS medicine·2019

相关实验视频

Updated: Jun 3, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

结核病是一种疾病.

Stephen D Lawn1, Alimuddin I Zumla

  • 1The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.

Lancet (London, England)
|March 23, 2011
PubMed
概括

结核病仍然是全球卫生危机,每年造成数百万人的死亡. 迫切的投资和政治承诺对于开发新的诊断方法,药物和疫苗来对抗这种持久的传染病至关重要.

科学领域:

  • 公共卫生 公共卫生
  • 传染性疾病 传染性疾病
  • 流行病学 流行病学

背景情况:

  • 结核病 (TB) 每年造成超过170万例死亡和900万新病例,不成比例地影响低收入和中等收入国家.
  • 艾滋病毒显著增加了结核病的易感性,特别是在撒哈拉以南非洲,那里有五分之四的艾滋病毒相关结核病病例发生.
  • 目前的结核病诊断 (唾液显微镜) 和治疗方法不足,面临药物耐药性和长时间治疗方案的挑战.

研究的目的:

  • 介绍有关全球结核病流行病的当前观点.
  • 审查病原体,宿主反应和结核病的新兴控制方法.
  • 突出21世纪结核病控制的持续挑战.

主要方法:

  • 关于结核病的当前科学文献和研究的综述.
  • 对结核病发病率,死亡率和耐药性的流行病学数据的分析.
  • 综合有关结核病诊断,生物标志物,药物和疫苗的信息.

主要成果:

  • 基础科学和翻译研究取得的重大进展,在结核病诊断,生物标志物,药物和疫苗方面取得了有前途的进展.
  • 耐药结核病的增长率威胁着全球控制努力.
  • 对结核病病原体的基本理解仍然不足.

相关实验视频

Last Updated: Jun 3, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

结论:

  • 尽管取得了进展,但结核病仍然是全球重大公共卫生挑战,需要增加投资和政治承诺.
  • 新的诊断,有效的药物和疫苗对于控制结核病流行病至关重要.
  • 应对结核病控制的多方面的挑战需要全面和持续的全球努力.